Please subscribe to receive our research, articles and invitations as soon as they are available. Our research is classified as a ‘minor non-monetary benefit’ as defined by the Markets in Financial Instruments Directive II.

Diurnal Group

16 September 2020 

Initiation of Coverage

11 November 2020 

Introducing DITEST

30 September 2020 

Alkindi US Approval


Calvine Partners LLP, Registered in Scotland, Partnership No. SO306987

Registered address: 23 Melville Street, Edinburgh, EH3 7PE

Privacy Policy